CN113476391A - 一种用于快速修护晒伤的组合物及其制备方法与用途 - Google Patents
一种用于快速修护晒伤的组合物及其制备方法与用途 Download PDFInfo
- Publication number
- CN113476391A CN113476391A CN202110859718.6A CN202110859718A CN113476391A CN 113476391 A CN113476391 A CN 113476391A CN 202110859718 A CN202110859718 A CN 202110859718A CN 113476391 A CN113476391 A CN 113476391A
- Authority
- CN
- China
- Prior art keywords
- parts
- extract
- phase
- composition
- ceramide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 75
- 206010042496 Sunburn Diseases 0.000 title claims abstract description 62
- 238000002360 preparation method Methods 0.000 title abstract description 16
- 239000000284 extract Substances 0.000 claims abstract description 88
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 71
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims abstract description 24
- 229920000058 polyacrylate Polymers 0.000 claims abstract description 16
- 230000008439 repair process Effects 0.000 claims abstract description 14
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims abstract description 12
- AERBNCYCJBRYDG-UHFFFAOYSA-N D-ribo-phytosphingosine Natural products CCCCCCCCCCCCCCC(O)C(O)C(N)CO AERBNCYCJBRYDG-UHFFFAOYSA-N 0.000 claims abstract description 12
- 240000002505 Pogostemon cablin Species 0.000 claims abstract description 12
- 235000011751 Pogostemon cablin Nutrition 0.000 claims abstract description 12
- 229920002367 Polyisobutene Polymers 0.000 claims abstract description 12
- 229920002125 Sokalan® Polymers 0.000 claims abstract description 12
- 229960001631 carbomer Drugs 0.000 claims abstract description 12
- 235000012000 cholesterol Nutrition 0.000 claims abstract description 12
- 229920001577 copolymer Polymers 0.000 claims abstract description 12
- 239000004205 dimethyl polysiloxane Substances 0.000 claims abstract description 12
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 claims abstract description 12
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims abstract description 12
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims abstract description 12
- AERBNCYCJBRYDG-KSZLIROESA-N phytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@@H](N)CO AERBNCYCJBRYDG-KSZLIROESA-N 0.000 claims abstract description 12
- 229940033329 phytosphingosine Drugs 0.000 claims abstract description 12
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims abstract description 12
- -1 polydimethylsiloxane Polymers 0.000 claims abstract description 12
- NTYZDAJPNNBYED-UHFFFAOYSA-M sodium;2-(2-dodecanoyloxypropanoyloxy)propanoate Chemical compound [Na+].CCCCCCCCCCCC(=O)OC(C)C(=O)OC(C)C([O-])=O NTYZDAJPNNBYED-UHFFFAOYSA-M 0.000 claims abstract description 12
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000000230 xanthan gum Substances 0.000 claims abstract description 12
- 229920001285 xanthan gum Polymers 0.000 claims abstract description 12
- 229940082509 xanthan gum Drugs 0.000 claims abstract description 12
- 235000010493 xanthan gum Nutrition 0.000 claims abstract description 12
- BBAFBDLICMHBNU-MFZOPHKMSA-N N-(2-hydroxyoctadecanoyl)-4-hydroxysphinganine Chemical compound CCCCCCCCCCCCCCCCC(O)C(=O)N[C@@H](CO)[C@H](O)[C@H](O)CCCCCCCCCCCCCC BBAFBDLICMHBNU-MFZOPHKMSA-N 0.000 claims abstract description 11
- 229940095137 ceramide 6 ii Drugs 0.000 claims abstract description 11
- 241001672739 Artemia salina Species 0.000 claims abstract description 10
- 229940084801 salvia miltiorrhiza root extract Drugs 0.000 claims abstract description 10
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 claims abstract description 9
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229940087291 tridecyl alcohol Drugs 0.000 claims abstract description 9
- 229940059958 centella asiatica extract Drugs 0.000 claims abstract description 6
- ATGQXSBKTQANOH-UWVGARPKSA-N N-oleoylphytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@H](CO)NC(=O)CCCCCCC\C=C/CCCCCCCC ATGQXSBKTQANOH-UWVGARPKSA-N 0.000 claims abstract description 4
- 229920001213 Polysorbate 20 Polymers 0.000 claims abstract description 4
- MIUIRGGKIICMBP-NFOZDHADSA-N [27-oxo-27-[[(2s,3s,4r)-1,3,4-trihydroxyoctadecan-2-yl]amino]heptacosyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)[C@H](O)CCCCCCCCCCCCCC MIUIRGGKIICMBP-NFOZDHADSA-N 0.000 claims abstract description 4
- 229940082463 angelica sinensis root extract Drugs 0.000 claims abstract description 4
- 229940048864 ceramide 1 Drugs 0.000 claims abstract description 4
- 229940044176 ceramide 3 Drugs 0.000 claims abstract description 4
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims abstract description 4
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims abstract description 4
- 229940068977 polysorbate 20 Drugs 0.000 claims abstract description 4
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 claims description 24
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 claims description 24
- 229940106189 ceramide Drugs 0.000 claims description 24
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 claims description 24
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 claims description 24
- 238000003756 stirring Methods 0.000 claims description 24
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 22
- YPFDHNVEDLHUCE-UHFFFAOYSA-N propane-1,3-diol Chemical compound OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 claims description 22
- 238000002156 mixing Methods 0.000 claims description 15
- 230000001804 emulsifying effect Effects 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 14
- 239000002994 raw material Substances 0.000 claims description 13
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 12
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 12
- 239000011734 sodium Substances 0.000 claims description 12
- 229910052708 sodium Inorganic materials 0.000 claims description 12
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims description 11
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 11
- 239000004475 Arginine Substances 0.000 claims description 11
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 11
- 229920006037 cross link polymer Polymers 0.000 claims description 11
- 239000001642 eugenia caryophyllata l. bud extract Substances 0.000 claims description 11
- 229960005323 phenoxyethanol Drugs 0.000 claims description 11
- 239000004302 potassium sorbate Substances 0.000 claims description 11
- 229940069338 potassium sorbate Drugs 0.000 claims description 11
- 235000010241 potassium sorbate Nutrition 0.000 claims description 11
- RUOJZAUFBMNUDX-UHFFFAOYSA-N propylene carbonate Chemical compound CC1COC(=O)O1 RUOJZAUFBMNUDX-UHFFFAOYSA-N 0.000 claims description 11
- FBNAWLJSQORPAX-UHFFFAOYSA-N 4-methyl-3-propan-2-ylphenol Chemical compound CC(C)C1=CC(O)=CC=C1C FBNAWLJSQORPAX-UHFFFAOYSA-N 0.000 claims description 9
- JUIUXBHZFNHITF-IEOSBIPESA-N [(2r)-2,5,7,8-tetramethyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] dihydrogen phosphate Chemical compound OP(=O)(O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C JUIUXBHZFNHITF-IEOSBIPESA-N 0.000 claims description 9
- 229940081733 cetearyl alcohol Drugs 0.000 claims description 9
- ANZUDYZHSVGBRF-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol Chemical compound CCCCCCC(O)(CC)C(O)CO ANZUDYZHSVGBRF-UHFFFAOYSA-N 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 8
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims description 8
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 claims description 8
- 229930003799 tocopherol Natural products 0.000 claims description 8
- 229960001295 tocopherol Drugs 0.000 claims description 8
- 239000011732 tocopherol Substances 0.000 claims description 8
- 235000010384 tocopherol Nutrition 0.000 claims description 8
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 8
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 claims description 7
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims description 7
- 239000009188 angelicae sinensis extract Substances 0.000 claims description 7
- 238000001816 cooling Methods 0.000 claims description 7
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 claims description 7
- 238000010438 heat treatment Methods 0.000 claims description 7
- 239000006071 cream Substances 0.000 claims description 6
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 claims description 6
- 238000005303 weighing Methods 0.000 claims description 6
- 239000001180 angelica archangelica l. root extract Substances 0.000 claims description 5
- LXAHHHIGZXPRKQ-UHFFFAOYSA-N 5-fluoro-2-methylpyridine Chemical compound CC1=CC=C(F)C=N1 LXAHHHIGZXPRKQ-UHFFFAOYSA-N 0.000 claims description 4
- 241000628997 Flos Species 0.000 claims description 4
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 3
- CQKHFONAFZDDKV-VAWYXSNFSA-N (e)-dodec-1-en-1-ol Chemical compound CCCCCCCCCC\C=C\O CQKHFONAFZDDKV-VAWYXSNFSA-N 0.000 claims description 3
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 claims description 3
- 241001529821 Agastache Species 0.000 claims description 3
- 244000025254 Cannabis sativa Species 0.000 claims description 3
- 241000237890 Haliotis Species 0.000 claims description 3
- 235000018142 Hedysarum alpinum var americanum Nutrition 0.000 claims description 3
- 240000006461 Hedysarum alpinum var. americanum Species 0.000 claims description 3
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 3
- 229910019142 PO4 Inorganic materials 0.000 claims description 3
- 241000207929 Scutellaria Species 0.000 claims description 3
- 229940100524 ethylhexylglycerin Drugs 0.000 claims description 3
- RGUVUPQQFXCJFC-UHFFFAOYSA-N n-hydroxyoctanamide Chemical compound CCCCCCCC(=O)NO RGUVUPQQFXCJFC-UHFFFAOYSA-N 0.000 claims description 3
- 239000010452 phosphate Substances 0.000 claims description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 3
- SMYKBXMWXCZOLU-UHFFFAOYSA-N tris-decyl benzene-1,2,4-tricarboxylate Chemical compound CCCCCCCCCCOC(=O)C1=CC=C(C(=O)OCCCCCCCCCC)C(C(=O)OCCCCCCCCCC)=C1 SMYKBXMWXCZOLU-UHFFFAOYSA-N 0.000 claims description 3
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 claims description 3
- 206010061218 Inflammation Diseases 0.000 abstract description 12
- 230000006870 function Effects 0.000 abstract description 7
- 240000004534 Scutellaria baicalensis Species 0.000 abstract description 4
- 235000017089 Scutellaria baicalensis Nutrition 0.000 abstract description 4
- 229940082500 cetostearyl alcohol Drugs 0.000 abstract description 3
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 abstract description 3
- 230000003115 biocidal effect Effects 0.000 abstract description 2
- 238000004321 preservation Methods 0.000 abstract description 2
- 235000011187 glycerol Nutrition 0.000 abstract 2
- 244000297179 Syringa vulgaris Species 0.000 abstract 1
- 235000004338 Syringa vulgaris Nutrition 0.000 abstract 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 45
- 230000000694 effects Effects 0.000 description 12
- 230000004054 inflammatory process Effects 0.000 description 10
- 208000024891 symptom Diseases 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 6
- 206010015150 Erythema Diseases 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 5
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 244000132619 red sage Species 0.000 description 5
- 230000008591 skin barrier function Effects 0.000 description 5
- 241000238582 Artemia Species 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 229920001436 collagen Polymers 0.000 description 4
- 230000003020 moisturizing effect Effects 0.000 description 4
- 210000004927 skin cell Anatomy 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 231100000321 erythema Toxicity 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 101800005049 Beta-endorphin Proteins 0.000 description 2
- 102000009135 CB2 Cannabinoid Receptor Human genes 0.000 description 2
- 108010073376 CB2 Cannabinoid Receptor Proteins 0.000 description 2
- 102100036214 Cannabinoid receptor 2 Human genes 0.000 description 2
- 101710187022 Cannabinoid receptor 2 Proteins 0.000 description 2
- 244000146462 Centella asiatica Species 0.000 description 2
- 235000004032 Centella asiatica Nutrition 0.000 description 2
- 208000001840 Dandruff Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 102100027467 Pro-opiomelanocortin Human genes 0.000 description 2
- 206010040830 Skin discomfort Diseases 0.000 description 2
- 244000223014 Syzygium aromaticum Species 0.000 description 2
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 2
- 108010025083 TRPV1 receptor Proteins 0.000 description 2
- AIGAZQPHXLWMOJ-UHFFFAOYSA-N Tanshinone I Chemical compound C1=CC2=C(C)C=CC=C2C(C(=O)C2=O)=C1C1=C2C(C)=CO1 AIGAZQPHXLWMOJ-UHFFFAOYSA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- WOPZMFQRCBYPJU-NTXHZHDSSA-N beta-endorphin Chemical compound C([C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C1=CC=CC=C1 WOPZMFQRCBYPJU-NTXHZHDSSA-N 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 239000001649 glycyrrhiza glabra l. absolute Substances 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 229940051810 licorice root extract Drugs 0.000 description 2
- 235000020725 licorice root extract Nutrition 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 210000003470 mitochondria Anatomy 0.000 description 2
- 238000013021 overheating Methods 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 210000001732 sebaceous gland Anatomy 0.000 description 2
- 230000037307 sensitive skin Effects 0.000 description 2
- 238000004781 supercooling Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 210000003556 vascular endothelial cell Anatomy 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 1
- 241001288870 Angelica polymorpha Species 0.000 description 1
- 241000382455 Angelica sinensis Species 0.000 description 1
- FXNFHKRTJBSTCS-UHFFFAOYSA-N Baicalein Natural products C=1C(=O)C=2C(O)=C(O)C(O)=CC=2OC=1C1=CC=CC=C1 FXNFHKRTJBSTCS-UHFFFAOYSA-N 0.000 description 1
- 108091006146 Channels Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 240000007164 Salvia officinalis Species 0.000 description 1
- 239000010404 Scutellaria baicalensis extract Substances 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 206010040844 Skin exfoliation Diseases 0.000 description 1
- 206010040914 Skin reaction Diseases 0.000 description 1
- 206010041303 Solar dermatitis Diseases 0.000 description 1
- 229930183118 Tanshinone Natural products 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- UDFLTIRFTXWNJO-UHFFFAOYSA-N baicalein Chemical compound O1C2=CC(=O)C(O)=C(O)C2=C(O)C=C1C1=CC=CC=C1 UDFLTIRFTXWNJO-UHFFFAOYSA-N 0.000 description 1
- 229940015301 baicalein Drugs 0.000 description 1
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 description 1
- 229960003321 baicalin Drugs 0.000 description 1
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000002032 cellular defenses Effects 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 230000035618 desquamation Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000011477 liquorice Nutrition 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- LFGREXWGYUGZLY-UHFFFAOYSA-N phosphoryl Chemical group [P]=O LFGREXWGYUGZLY-UHFFFAOYSA-N 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000007348 radical reaction Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 235000005412 red sage Nutrition 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 230000035483 skin reaction Effects 0.000 description 1
- 231100000430 skin reaction Toxicity 0.000 description 1
- 230000036555 skin type Effects 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/342—Alcohols having more than seven atoms in an unbroken chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4993—Derivatives containing from 2 to 10 oxyalkylene groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8105—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
- A61K8/8111—Homopolymers or copolymers of aliphatic olefines, e.g. polyethylene, polyisobutene; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8147—Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/004—Aftersun preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Zoology (AREA)
- Cosmetics (AREA)
Abstract
本发明公开了一种用于快速修护晒伤的组合物及其制备方法与用途，该组合物包含：辛酸/癸酸甘油三酯、甘油、鲸蜡硬脂醇、氢化聚异丁烯、十三烷醇偏苯三酸酯、聚二甲基硅氧烷、甘油聚丙烯酸酯、PVM/MA共聚物、植物鞘氨醇、胆甾醇、月桂酰乳酰乳酸钠、卡波姆、黄原胶、水、卤虫提取物、聚丙烯酸酯‑13、聚异丁烯、聚山梨醇酯‑20、积雪草提取物、丹参根提取物、丁香花蕾提取物、黄芩根提取物、当归根提取物、甘草根提取物、辛基十二醇、广藿香叶提取物、神经酰胺3、神经酰胺6II、神经酰胺1等。本发明还提供了该组合物的制备方法与用途。本发明的组合物能针对性不同原因引起的皮肤晒伤，并促进皮肤修复、保湿、抗菌及抗炎功能等。
Description
技术领域
本发明涉及一种用于化妆品领域的解决皮肤晒伤症状的组合物及其制备方法与用途，具体地，涉及一种用于快速修护晒伤的组合物及其制备方法与用途。
背景技术
晒伤即急性阳光性炎症，是皮肤接受强烈光线照射引起的一种急性损伤性皮肤反应，通常会出现红肿、灼烧、疼痛，甚至出现水疱、灼痛、皮肤脱屑等症状。日照性皮炎是皮肤接受的光照过强，暴露时间过长。当皮肤接受的紫外线超过了耐受量，紫外线根据波长不同，可以分为UVA、UVB、UVC，UVB是引起晒伤的主要原因，会使引起鲜红色红斑；UVA引起深红色红斑；UVC引起粉红色红斑。紫外线的辐射改变人真皮层细胞基因状态，使人真皮层细胞释放多种炎症因子，引起真皮内血管扩张、渗透性增加。晒伤的治疗包括对皮肤的对症治疗和缓解疼痛，以局部外用药物为主。由于晒伤分类及症状的复杂性和多样性，目前无可以快速缓解治疗各类晒伤的产品。
发明内容
本发明的目的是提供一种适用于所有肤质的快速修护晒伤的组合物制备及在护肤品中的应用，能够解决现有问题，针对不同原因引起的皮肤晒伤，并能促进皮肤修复、保湿、抗菌及抗炎功能等。
为了达到上述目的，本发明提供了一种用于快速修护晒伤的组合物，其中，该组合物包含A相、B相、C相、D相；A相包含辛酸/癸酸甘油三酯、甘油、鲸蜡硬脂醇、氢化聚异丁烯、十三烷醇偏苯三酸酯、聚二甲基硅氧烷、甘油聚丙烯酸酯、PVM/MA共聚物、植物鞘氨醇、胆甾醇、月桂酰乳酰乳酸钠、卡波姆、黄原胶，以及水；B相包含卤虫提取物、聚丙烯酸酯-13、聚异丁烯、聚山梨醇酯-20、积雪草提取物、丹参根提取物、丁香花蕾提取物、黄芩根提取物、当归根提取物；C相包含甘草根提取物、辛基十二醇、广藿香叶提取物；D相包含神经酰胺3、神经酰胺6II、神经酰胺1、丁二醇、苯氧乙醇、1,3-丙二醇、碳酸丙二醇酯、辛酰羟肟酸、o-伞花烃-5-醇、精氨酸、丙烯酸酯类/C10-30烷醇丙烯酸酯交联聚合物、生育酚磷酸酯钠、EDTA二钠、乙基己基甘油、山梨酸钾。
上述的用于快速修护晒伤的组合物，其中，所述的组合物中按重量份数计包含：辛酸/癸酸甘油三酯2～4份、甘油0.5～1.5份、鲸蜡硬脂醇2～4份、氢化聚异丁烯0.5～1.5份、十三烷醇偏苯三酸酯2～4份、聚二甲基硅氧烷2～4份、甘油聚丙烯酸酯1～2份、PVM/MA共聚物0.5～1.5份、植物鞘氨醇2～4份、胆甾醇2～4份、月桂酰乳酰乳酸钠0.4～0.6份、卡波姆0.05～0.15份、黄原胶0.2～0.4份、卤虫提取物2～4份、聚丙烯酸酯-13 2～3份、聚异丁烯0.5～1.5份、聚山梨醇酯-20 0.4～0.6份、积雪草提取物0.5～1.5份、丹参根提取物0.5～1.5份、丁香花蕾提取物0.5～1.5份、黄芩根提取物0.5～1.5份、当归根提取物0.4～0.6份、甘草根提取物0.5～1.5份、辛基十二醇0.4～0.6份、广藿香叶提取物2～4份、神经酰胺3 4～6份、神经酰胺6II 4～6份、神经酰胺1 4～6份、丁二醇4～6份、苯氧乙醇1～3份、1,3-丙二醇1～3份、碳酸丙二醇酯2～4份、辛酰羟肟酸0.5～1.5份、o-伞花烃-5-醇1～2份、精氨酸0.2～0.4份、丙烯酸酯类/C10-30烷醇丙烯酸酯交联聚合物0.2～0.4份、生育酚磷酸酯钠1～3份、EDTA二钠0.4～0.6份、乙基己基甘油0.5～1.5份、山梨酸钾0.02～0.06份。
上述的用于快速修护晒伤的组合物，其中，所述的组合物中按质量百分比计包含：辛酸/癸酸甘油三酯3％、甘油1％、鲸蜡硬脂醇3％、氢化聚异丁烯1％、十三烷醇偏苯三酸酯3％、聚二甲基硅氧烷3％、甘油聚丙烯酸酯1.5％、PVM/MA共聚物1％、植物鞘氨醇3％、胆甾醇3％、月桂酰乳酰乳酸钠0.5％、卡波姆0.1％、黄原胶0.3％、卤虫提取物3％、聚丙烯酸酯-13 2.5％、聚异丁烯1％、聚山梨醇酯-20 0.5％、积雪草提取物1％、丹参根提取物1％、丁香花蕾提取物1％、黄芩根提取物1％、当归根提取物0.5％、甘草根提取物1％、辛基十二醇0.5％、广藿香叶提取物3％、神经酰胺3 5％、神经酰胺6II 5％、神经酰胺1 5％、丁二醇5％、苯氧乙醇2％、1,3-丙二醇2％、碳酸丙二醇酯3％、辛酰羟肟酸1％、o-伞花烃-5-醇1.5％、精氨酸0.3％、丙烯酸酯类/C10-30烷醇丙烯酸酯交联聚合物0.3％、生育酚磷酸酯钠2％、EDTA二钠0.5％、乙基己基甘油1％、山梨酸钾0.05％。
上述的用于快速修护晒伤的组合物，其中，所述的组合物中按质量百分比计加水到100％。
本发明还提供了一种上述的用于快速修护晒伤的组合物的制备方法，其中，所述的方法包含：步骤1、按比例称量各原料，并分为A相、B相、C相、D相；步骤2、分别将A相、B相加热；步骤3、在搅拌条件下将B相加入A相，混匀后，乳化；步骤4、再向混合物加入C相，混匀后，乳化，离心；步骤5、慢速搅拌冷却，最后加入D相搅拌均匀即可。
上述的用于快速修护晒伤的组合物的制备方法，其中，所述的步骤2中，分别将A相、B相加热至75℃。
上述的用于快速修护晒伤的组合物的制备方法，其中，所述的步骤3中，在搅拌条件下将B相加入A相，混匀后，以8000转/分钟的转速乳化2-3分钟。
上述的用于快速修护晒伤的组合物的制备方法，其中，所述的步骤4中，再向混合物加入C相，混匀后，以8000转/分钟的转速乳化2-3分钟，离心。
上述的用于快速修护晒伤的组合物的制备方法，其中，所述的步骤5中，慢速搅拌冷却至40℃，最后加入D相搅拌均匀。
本发明也提供了一种上述的方法制备的用于快速修护晒伤的组合物的用途，其中，所述的组合物用于制备护肤品；所述的护肤品包含修护乳膏。
本发明提供的用于快速修护晒伤的组合物及其制备方法与用途具有以下优点：
本发明专利涉及的快速修护晒伤的凝胶组合物首次将多种植物中药提取物(广藿香、丹参、丁香、黄芩、当归、甘草、积雪草等)、神经酰胺组合物、生育酚磷酸酯钠及卤虫提取物进行组合，适用于各种皮肤晒伤症状，在快速修复晒伤皮肤的同时，可以形成天然皮肤屏障，保湿锁水，抗炎抑菌等功能，从而改善紫外线敏感性肌肤，从而保持皮肤的水润与健康。
该组合物可以快速缓解晒伤引起的皮肤破损、发红、刺痛和皮屑等不适感，快速缓解由于晒伤而引起的炎症反应，同时具有超强的保湿能力，可以在形成天然的皮肤屏障，保湿锁水，抗炎抑菌。
具体实施方式
以下对本发明的具体实施方式作进一步地说明。
本发明提供的用于快速修护晒伤的组合物，包含A相、B相、C相、D相；A相包含辛酸/癸酸甘油三酯、甘油、鲸蜡硬脂醇、氢化聚异丁烯、十三烷醇偏苯三酸酯、聚二甲基硅氧烷、甘油聚丙烯酸酯、PVM/MA共聚物、植物鞘氨醇、胆甾醇、月桂酰乳酰乳酸钠、卡波姆、黄原胶，以及水；B相包含卤虫提取物、聚丙烯酸酯-13、聚异丁烯、聚山梨醇酯-20、积雪草提取物、丹参根提取物、丁香花蕾提取物、黄芩根提取物、当归根提取物；C相包含甘草根提取物、辛基十二醇、广藿香叶提取物；D相包含神经酰胺3、神经酰胺6II、神经酰胺1、丁二醇、苯氧乙醇、1,3-丙二醇、碳酸丙二醇酯、辛酰羟肟酸、o-伞花烃-5-醇、精氨酸、丙烯酸酯类/C10-30烷醇丙烯酸酯交联聚合物、生育酚磷酸酯钠、EDTA二钠、乙基己基甘油、山梨酸钾。
优选地，该组合物中按重量份数计包含：辛酸/癸酸甘油三酯2～4份、甘油0.5～1.5份、鲸蜡硬脂醇2～4份、氢化聚异丁烯0.5～1.5份、十三烷醇偏苯三酸酯2～4份、聚二甲基硅氧烷2～4份、甘油聚丙烯酸酯1～2份、PVM/MA共聚物0.5～1.5份、植物鞘氨醇2～4份、胆甾醇2～4份、月桂酰乳酰乳酸钠0.4～0.6份、卡波姆0.05～0.15份、黄原胶0.2～0.4份、卤虫提取物2～4份、聚丙烯酸酯-13 2～3份、聚异丁烯0.5～1.5份、聚山梨醇酯-20 0.4～0.6份、积雪草提取物0.5～1.5份、丹参根提取物0.5～1.5份、丁香花蕾提取物0.5～1.5份、黄芩根提取物0.5～1.5份、当归根提取物0.4～0.6份、甘草根提取物0.5～1.5份、辛基十二醇0.4～0.6份、广藿香叶提取物2～4份、神经酰胺3 4～6份、神经酰胺6II 4～6份、神经酰胺1 4～6份、丁二醇4～6份、苯氧乙醇1～3份、1,3-丙二醇1～3份、碳酸丙二醇酯2～4份、辛酰羟肟酸0.5～1.5份、o-伞花烃-5-醇1～2份、精氨酸0.2～0.4份、丙烯酸酯类/C10-30烷醇丙烯酸酯交联聚合物0.2～0.4份、生育酚磷酸酯钠1～3份、EDTA二钠0.4～0.6份、乙基己基甘油0.5～1.5份、山梨酸钾0.02～0.06份。
更优选地，该组合物中按质量百分比计包含：辛酸/癸酸甘油三酯3％、甘油1％、鲸蜡硬脂醇3％、氢化聚异丁烯1％、十三烷醇偏苯三酸酯3％、聚二甲基硅氧烷3％、甘油聚丙烯酸酯1.5％、PVM/MA共聚物1％、植物鞘氨醇3％、胆甾醇3％、月桂酰乳酰乳酸钠0.5％、卡波姆0.1％、黄原胶0.3％、卤虫提取物3％、聚丙烯酸酯-13 2.5％、聚异丁烯1％、聚山梨醇酯-20 0.5％、积雪草提取物1％、丹参根提取物1％、丁香花蕾提取物1％、黄芩根提取物1％、当归根提取物0.5％、甘草根提取物1％、辛基十二醇0.5％、广藿香叶提取物3％、神经酰胺3 5％、神经酰胺6II 5％、神经酰胺1 5％、丁二醇5％、苯氧乙醇2％、1,3-丙二醇2％、碳酸丙二醇酯3％、辛酰羟肟酸1％、o-伞花烃-5-醇1.5％、精氨酸0.3％、丙烯酸酯类/C10-30烷醇丙烯酸酯交联聚合物0.3％、生育酚磷酸酯钠2％、EDTA二钠0.5％、乙基己基甘油1％、山梨酸钾0.05％。
该组合物中按质量百分比计加水到100％。
本发明中的组合物主要功能成分有：神经酰胺组合物、卤虫(ARTEMIA)提取物、生育酚磷酸酯钠以及植物提取物(丹参(SALVIA MILTIORRHIZA)根提取物、丁香(EUGENIACARYOPHYLLUS)花蕾提取物、黄芩(SCUTELLARIA BAICALENSIS)根提取物、甘草根提取物、当归(ANGELICA POLYMORPHA SINENSIS)根提取物、积雪草(CENTELLA ASIATICA)提取物和广藿香(POGOSTEMON CABLIN)叶提取物)
神经酰胺组合物天然存在于人皮肤的角质层中，是皮肤自身免疫系统的一部分。可快速消除皮肤炎症，有效减轻灼烧症状，减少微生物对皮肤微生态的破坏。神经酰胺组合物能有效恢复皮肤的保护屏障功能，同时它还是天然的保湿成分，可以有效缓解晒伤症状。
卤虫提取物(即GP4G)，提取于嗜极浮游生物的核苷酸，具有多重防护和抗压靶向，它首先是细胞活化因子,可以激活人体皮肤细胞的各种生理活动和新陈代谢。其次它是细胞防御因子,在保护细胞抵御各种类型压力。可以有效抵御UV、红外、过热、过冷等压力造成的蛋白质、RNA、线粒体等的损伤，具有快速美白、修复的作用。
生育酚磷酸酯钠是一种水溶性的粉末状维生素E：利用磷酰基对生育酚中的羟基进行化学修饰和保护，避免发生氧化；皮肤所吸收的TPNa(R)会被皮肤中的磷酸酶迅速水解转化为具有活性的生育酚，进而发挥作用。它具有对抗UV、抑制各种炎症的功效，同时还可以增加皮肤中神经酰胺的合成，形成皮肤屏障，维持皮肤微生态。
广藿香(POGOSTEMON CABLIN)叶提取物，是大麻素受体2(CB2)激活剂，激活CB2受体、抑制TRPV1受体，促进β-内啡肽的合成，具有快速舒缓、抗刺激、修复皮肤的作用，能快速修复晒伤肌肤，对紫外线刺激引起的皮肤不适有很好的缓解效果。
丹参(SALVIA MILTIORRHIZA)根提取物中的丹参酮具有抗炎和抗菌能力，丹参根提取物具有抑制皮脂腺细胞增生和缩小皮脂腺细胞体积作用，起到保湿作用，有助于晒伤后皮肤的修复。
黄岑根提取物中的黄岑苷和黄岑素可以影响花生四烯酸通道，抑制细胞因子的特异性引起的炎症反应；具有极强地广谱性抑菌作用。所以其可以极速缓解由于晒伤而引起的各类炎症反应，还可以增强皮肤抗敏能力。
当归根提取物可以控制血管皮细胞的扩张，具有改善皮肤晒伤的作用；其良好的SOD样活性，可以抑制过氧化反应和自由基反应，与磷脂结合，保护生物膜，具有极强晒伤后修复能力。
甘草根提取物可以促进肌细胞和血管内皮细胞的增殖，促进胶原带白的生成，抑制NO的生成，增强皮肤免疫力，抗发炎及降低氧化速度，能改善对紫外线敏感的现象，安抚舒缓晒伤后的皮肤。
积雪草提取物为植物胶原蛋白，具有消肿解毒祛脓疮的作用；同时其可以促进皮肤胶原蛋白再生，增强细胞基底层细胞活力，调节皮肤免疫力。
本发明还提供了该用于快速修护晒伤的组合物的制备方法，包含：步骤1、按比例称量各原料，并分为A相、B相、C相、D相；步骤2、分别将A相、B相加热；步骤3、在搅拌条件下将B相加入A相，混匀后，乳化；步骤4、再向混合物加入C相，混匀后，乳化，离心；步骤5、慢速搅拌冷却，最后加入D相搅拌均匀即可。
步骤2中，分别将A相、B相加热至75℃。
步骤3中，在搅拌条件下将B相加入A相，混匀后，以8000转/分钟的转速乳化2-3分钟。
步骤4中，再向混合物加入C相，混匀后，以8000转/分钟的转速乳化2-3分钟，离心。
步骤5中，慢速搅拌冷却至40℃，最后加入D相搅拌均匀。
本发明也提供了该方法制备的用于快速修护晒伤的组合物的用途，该组合物用于制备护肤品；该护肤品包含修护乳膏。
下面结合实施例对本发明提供的用于快速修护晒伤的组合物及其制备方法与用途做更进一步描述。
实施例1
一种用于快速修护晒伤的组合物，成分如下表1所示。各原料分别符合相应的国家标准。
表1.组合物配料表(按质量百分比计)。
本实施例还提供了该用于快速修护晒伤的组合物的制备方法，包含：
步骤1、按比例称量各原料，并分为A相、B相、C相、D相。
步骤2、分别将A相、B相加热至75℃。
步骤3、在搅拌条件下将B相加入A相，混匀后，以8000转/分钟的转速乳化2-3分钟。
步骤4、再向混合物加入C相，混匀后，以8000转/分钟的转速乳化2-3分钟，离心。
步骤5、慢速搅拌冷却至40℃，最后加入D相搅拌均匀即可。
本实施例也提供了该方法制备的用于快速修护晒伤的组合物的用途，该组合物用于制备护肤品；该护肤品包含修护乳膏。
实施例2
一种用于快速修护晒伤的组合物，按重量份数计包含：
辛酸/癸酸甘油三酯2份、甘油0.5份、鲸蜡硬脂醇2份、氢化聚异丁烯0.5份、十三烷醇偏苯三酸酯2份、聚二甲基硅氧烷2份、甘油聚丙烯酸酯1份、PVM/MA共聚物0.5份、植物鞘氨醇2份、胆甾醇2份、月桂酰乳酰乳酸钠0.4份、卡波姆0.05份、黄原胶0.2份、卤虫提取物2份、聚丙烯酸酯-13 2份、聚异丁烯0.5份、聚山梨醇酯-20 0.4份、积雪草提取物0.5份、丹参根提取物0.5份、丁香花蕾提取物0.5份、黄芩根提取物0.5份、当归根提取物0.4份、甘草根提取物0.5份、辛基十二醇0.4份、广藿香叶提取物2份、神经酰胺3 4份、神经酰胺6II 4份、神经酰胺1 4份、丁二醇4份、苯氧乙醇1份、1,3-丙二醇1份、碳酸丙二醇酯2份、辛酰羟肟酸0.5份、o-伞花烃-5-醇1份、精氨酸0.2份、丙烯酸酯类/C10-30烷醇丙烯酸酯交联聚合物0.2份、生育酚磷酸酯钠1份、EDTA二钠0.4份、乙基己基甘油0.5份、山梨酸钾0.02份。
然后将该组合物按质量百分比计加水到100％。
本实施例还提供了该用于快速修护晒伤的组合物的制备方法，包含：
步骤1、按比例称量各原料，并分为A相、B相、C相、D相。
步骤2、分别将A相、B相加热至75℃。
步骤3、在搅拌条件下将B相加入A相，混匀后，以8000转/分钟的转速乳化2-3分钟。
步骤4、再向混合物加入C相，混匀后，以8000转/分钟的转速乳化2-3分钟，离心。
步骤5、慢速搅拌冷却至40℃，最后加入D相搅拌均匀即可。
本实施例也提供了该方法制备的用于快速修护晒伤的组合物的用途，该组合物用于制备护肤品；该护肤品包含修护乳膏。
实施例3
一种用于快速修护晒伤的组合物，按重量份数计包含：
辛酸/癸酸甘油三酯4份、甘油1.5份、鲸蜡硬脂醇4份、氢化聚异丁烯1.5份、十三烷醇偏苯三酸酯4份、聚二甲基硅氧烷4份、甘油聚丙烯酸酯2份、PVM/MA共聚物1.5份、植物鞘氨醇4份、胆甾醇4份、月桂酰乳酰乳酸钠0.6份、卡波姆0.15份、黄原胶0.4份、卤虫提取物4份、聚丙烯酸酯-13 3份、聚异丁烯1.5份、聚山梨醇酯-20 0.6份、积雪草提取物1.5份、丹参根提取物1.5份、丁香花蕾提取物1.5份、黄芩根提取物1.5份、当归根提取物0.6份、甘草根提取物1.5份、辛基十二醇0.6份、广藿香叶提取物4份、神经酰胺3 6份、神经酰胺6II 6份、神经酰胺1 6份、丁二醇6份、苯氧乙醇3份、1,3-丙二醇3份、碳酸丙二醇酯4份、辛酰羟肟酸1.5份、o-伞花烃-5-醇2份、精氨酸0.4份、丙烯酸酯类/C10-30烷醇丙烯酸酯交联聚合物0.4份、生育酚磷酸酯钠3份、EDTA二钠0.6份、乙基己基甘油1.5份、山梨酸钾0.06份。
然后将该组合物按质量百分比计加水到100％。
本实施例还提供了该用于快速修护晒伤的组合物的制备方法，包含：
步骤1、按比例称量各原料，并分为A相、B相、C相、D相。
步骤2、分别将A相、B相加热至75℃。
步骤3、在搅拌条件下将B相加入A相，混匀后，以8000转/分钟的转速乳化2-3分钟。
步骤4、再向混合物加入C相，混匀后，以8000转/分钟的转速乳化2-3分钟，离心。
步骤5、慢速搅拌冷却至40℃，最后加入D相搅拌均匀即可。
本实施例也提供了该方法制备的用于快速修护晒伤的组合物的用途，该组合物用于制备护肤品；该护肤品包含修护乳膏。
采用各实施例制备的组合物进行测试及评估，具体方式如下。
1.实验对象
实验组(本发明)：50例，男25例，女25例；年龄10-42岁；
对照组(安慰剂-普通保湿液)：50例，男25例，女25例，年龄12-50岁。
两组人员的性别、年龄等资料经统计学处理，差异无统计学意义(P>0.05)，两组有可比性。
2.治疗方式，对实验组晒伤处涂抹本发明，对照组晒伤处涂抹普通保湿液，记录晒伤修复时间并作如下评估，记录不适反应的发生。
3.评估标准：
根据皮肤晒斑、发红、刺痛和皮屑情况进行评价。
痊愈：症状及体征消退95％以上。
显效：临床表现减轻80％-94％。
好转：临表现减轻50％-79％。
无效：临床表现无改善。
4.结果：结果如下表2所示。
表2.测试结果表。
对实验组与对照组进行差异性分析(P＜0.05)有显著差异，具有统计学意义。实验组有效率明显高于对照组有效率，说明实验组可以快速修护晒伤症状，同时实验组未产生不适发生，说明该发明具有良好效果。
本发明采用的成分中，神经酰胺组合物可以快速消除皮肤炎症、缓解灼烧症状，快速恢复皮肤的保护屏障功能，有效抵御病原微生物。卤虫提取物(即GP4G)可以细胞活化因子,激活人体皮肤细胞的各种生理活动和新陈代谢。同时可以有效抵御UV、红外、过热、过冷等压力造成的蛋白质、RNA、线粒体等的损伤，具有快速修复晒伤的作用。生育酚磷酸酯钠是一种维生素E，它具有对抗UV、抑制各种炎症的功效，同时还可以增加皮肤中神经酰胺的合成，形成皮肤屏障，维持皮肤微生态。广藿香(POGOSTEMON CABLIN)叶提取物可以激活CB2受体、抑制TRPV1受体，促进β-内啡肽的合成，具有快速舒缓、抗刺激、修复皮肤的作用，能快速修复晒伤肌肤，对紫外线刺激引起的皮肤不适有很好的缓解效果。
本发明提供的用于快速修护晒伤的组合物及其制备方法与用途，具有修复皮肤屏障，保湿锁水，抗炎抑菌等功能，可以达到快速修护晒伤效果，从而改善紫外线敏感性肌肤，从而保持皮肤的水润与健康。
尽管本发明的内容已经通过上述优选实施例作了详细介绍，但应当认识到上述的描述不应被认为是对本发明的限制。在本领域技术人员阅读了上述内容后，对于本发明的多种修改和替代都将是显而易见的。因此，本发明的保护范围应由所附的权利要求来限定。
Claims (10)
1.一种用于快速修护晒伤的组合物，其特征在于，该组合物包含A相、B相、C相、D相；
A相包含辛酸/癸酸甘油三酯、甘油、鲸蜡硬脂醇、氢化聚异丁烯、十三烷醇偏苯三酸酯、聚二甲基硅氧烷、甘油聚丙烯酸酯、PVM/MA共聚物、植物鞘氨醇、胆甾醇、月桂酰乳酰乳酸钠、卡波姆、黄原胶，以及水；
B相包含卤虫提取物、聚丙烯酸酯-13、聚异丁烯、聚山梨醇酯-20、积雪草提取物、丹参根提取物、丁香花蕾提取物、黄芩根提取物、当归根提取物；
C相包含甘草根提取物、辛基十二醇、广藿香叶提取物；
D相包含神经酰胺3、神经酰胺6II、神经酰胺1、丁二醇、苯氧乙醇、1,3-丙二醇、碳酸丙二醇酯、辛酰羟肟酸、o-伞花烃-5-醇、精氨酸、丙烯酸酯类/C10-30烷醇丙烯酸酯交联聚合物、生育酚磷酸酯钠、EDTA二钠、乙基己基甘油、山梨酸钾。
2.如权利要求1所述的用于快速修护晒伤的组合物，其特征在于，所述的组合物中按重量份数计包含：辛酸/癸酸甘油三酯2～4份、甘油0.5～1.5份、鲸蜡硬脂醇2～4份、氢化聚异丁烯0.5～1.5份、十三烷醇偏苯三酸酯2～4份、聚二甲基硅氧烷2～4份、甘油聚丙烯酸酯1～2份、PVM/MA共聚物0.5～1.5份、植物鞘氨醇2～4份、胆甾醇2～4份、月桂酰乳酰乳酸钠0.4～0.6份、卡波姆0.05～0.15份、黄原胶0.2～0.4份、卤虫提取物2～4份、聚丙烯酸酯-132～3份、聚异丁烯0.5～1.5份、聚山梨醇酯-20 0.4～0.6份、积雪草提取物0.5～1.5份、丹参根提取物0.5～1.5份、丁香花蕾提取物0.5～1.5份、黄芩根提取物0.5～1.5份、当归根提取物0.4～0.6份、甘草根提取物0.5～1.5份、辛基十二醇0.4～0.6份、广藿香叶提取物2～4份、神经酰胺3 4～6份、神经酰胺6II 4～6份、神经酰胺1 4～6份、丁二醇4～6份、苯氧乙醇1～3份、1,3-丙二醇1～3份、碳酸丙二醇酯2～4份、辛酰羟肟酸0.5～1.5份、o-伞花烃-5-醇1～2份、精氨酸0.2～0.4份、丙烯酸酯类/C10-30烷醇丙烯酸酯交联聚合物0.2～0.4份、生育酚磷酸酯钠1～3份、EDTA二钠0.4～0.6份、乙基己基甘油0.5～1.5份、山梨酸钾0.02～0.06份。
3.如权利要求2所述的用于快速修护晒伤的组合物，其特征在于，所述的组合物中按质量百分比计包含：辛酸/癸酸甘油三酯3％、甘油1％、鲸蜡硬脂醇3％、氢化聚异丁烯1％、十三烷醇偏苯三酸酯3％、聚二甲基硅氧烷3％、甘油聚丙烯酸酯1.5％、PVM/MA共聚物1％、植物鞘氨醇3％、胆甾醇3％、月桂酰乳酰乳酸钠0.5％、卡波姆0.1％、黄原胶0.3％、卤虫提取物3％、聚丙烯酸酯-13 2.5％、聚异丁烯1％、聚山梨醇酯-20 0.5％、积雪草提取物1％、丹参根提取物1％、丁香花蕾提取物1％、黄芩根提取物1％、当归根提取物0.5％、甘草根提取物1％、辛基十二醇0.5％、广藿香叶提取物3％、神经酰胺3 5％、神经酰胺6II 5％、神经酰胺1 5％、丁二醇5％、苯氧乙醇2％、1,3-丙二醇2％、碳酸丙二醇酯3％、辛酰羟肟酸1％、o-伞花烃-5-醇1.5％、精氨酸0.3％、丙烯酸酯类/C10-30烷醇丙烯酸酯交联聚合物0.3％、生育酚磷酸酯钠2％、EDTA二钠0.5％、乙基己基甘油1％、山梨酸钾0.05％。
4.如权利要求3所述的用于快速修护晒伤的组合物，其特征在于，所述的组合物中按质量百分比计加水到100％。
5.一种如权利要求1～4中任意一项所述的用于快速修护晒伤的组合物的制备方法，其特征在于，所述的方法包含：
步骤1、按比例称量各原料，并分为A相、B相、C相、D相；
步骤2、分别将A相、B相加热；
步骤3、在搅拌条件下将B相加入A相，混匀后，乳化；
步骤4、再向混合物加入C相，混匀后，乳化，离心；
步骤5、慢速搅拌冷却，最后加入D相搅拌均匀即可。
6.如权利要求5所述的用于快速修护晒伤的组合物的制备方法，其特征在于，所述的步骤2中，分别将A相、B相加热至75℃。
7.如权利要求5所述的用于快速修护晒伤的组合物的制备方法，其特征在于，所述的步骤3中，在搅拌条件下将B相加入A相，混匀后，以8000转/分钟的转速乳化2-3分钟。
8.如权利要求5所述的用于快速修护晒伤的组合物的制备方法，其特征在于，所述的步骤4中，再向混合物加入C相，混匀后，以8000转/分钟的转速乳化2-3分钟，离心。
9.如权利要求5所述的用于快速修护晒伤的组合物的制备方法，其特征在于，所述的步骤5中，慢速搅拌冷却至40℃，最后加入D相搅拌均匀。
10.一种如权利要求5所述的方法制备的用于快速修护晒伤的组合物的用途，其特征在于，所述的组合物用于制备护肤品；所述的护肤品包含修护乳膏。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110859718.6A CN113476391A (zh) | 2021-07-28 | 2021-07-28 | 一种用于快速修护晒伤的组合物及其制备方法与用途 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110859718.6A CN113476391A (zh) | 2021-07-28 | 2021-07-28 | 一种用于快速修护晒伤的组合物及其制备方法与用途 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113476391A true CN113476391A (zh) | 2021-10-08 |
Family
ID=77944382
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110859718.6A Pending CN113476391A (zh) | 2021-07-28 | 2021-07-28 | 一种用于快速修护晒伤的组合物及其制备方法与用途 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113476391A (zh) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110742852A (zh) * | 2019-11-15 | 2020-02-04 | 上海百好博化工有限公司 | 一种用于多效修复敏感肌肤的组合物及制备方法与用途 |
| CN113133953A (zh) * | 2021-04-26 | 2021-07-20 | 上海赛儿生物科技有限公司 | 一种快速舒缓保湿强韧敏感皮肤的组合物及其制备方法与用途 |
-
2021
- 2021-07-28 CN CN202110859718.6A patent/CN113476391A/zh active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110742852A (zh) * | 2019-11-15 | 2020-02-04 | 上海百好博化工有限公司 | 一种用于多效修复敏感肌肤的组合物及制备方法与用途 |
| CN113133953A (zh) * | 2021-04-26 | 2021-07-20 | 上海赛儿生物科技有限公司 | 一种快速舒缓保湿强韧敏感皮肤的组合物及其制备方法与用途 |
Non-Patent Citations (1)
| Title |
|---|
| 上海梦希生物科技有限公司: "《U聚悦修护精华霜》", 《国产普通化妆品备案信息》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105616283B (zh) | 一种植物精粹修护面霜 | |
| CN107802559B (zh) | 美白组合物及其制备方法和用途 | |
| CN110731974B (zh) | 具有增强的抗炎功效的皮肤外用组合物 | |
| CN106455651A (zh) | 用于降低氧化胁迫的表面用组合物和方法 | |
| CN110755321A (zh) | 一种用于快速舒敏修护的组合物及制备方法与用途 | |
| CN109172432A (zh) | 保湿修复组合物及其应用 | |
| CN110420155B (zh) | 一种用于户外越野后的晒后修复抗过敏面膜及其制备方法 | |
| CN115025024B (zh) | 一种祛痘消印组合物及其应用 | |
| AU2012286357A1 (en) | Eucommia extract, preparation method therefor and use thereof | |
| CN103961291B (zh) | 一种土香薷提取液及其制备方法和应用 | |
| CN110638668A (zh) | 沉香精油面霜及其制备方法 | |
| KR20220168132A (ko) | 소나무 수피 추출물을 포함하는 부종완화, 셀룰라이트 감소 및 미백 효능을 갖는 피부용 조성물 및 이를 이용한 피부용 크림 | |
| CN109549901A (zh) | 一种淡纹亮泽颈霜及其制备方法 | |
| CN109966193A (zh) | 一种改善皮肤功能的组合物及其制备方法和应用 | |
| CN108379197A (zh) | 一种皮肤屏障修复保湿面膜及其制备方法 | |
| CN111228154A (zh) | 一种婴儿小麦鲜萃原浆乳及其制备方法 | |
| CN110974775A (zh) | 一种含葛仙米的舒敏组合物及其制备方法和应用 | |
| CN113476394A (zh) | 一种有效调节皮肤干燥脱屑的组合物及其制备方法与用途 | |
| CN113476391A (zh) | 一种用于快速修护晒伤的组合物及其制备方法与用途 | |
| CN111374935A (zh) | 含多肽的组合物及其应用 | |
| CN113262190B (zh) | 一种抗皮肤老化的外用组合物及其应用 | |
| CN113491664A (zh) | 一种用于快速缓解瘙痒的组合物及其制备方法与用途 | |
| CN113440470A (zh) | 一种有效缓解熬夜皮肤不适感的组合物其制备方法与用途 | |
| CN115487131A (zh) | 一种日用面部皮肤护肤组合物及其制备方法 | |
| CN115778870A (zh) | 一种抗皱抗衰老的组合物及其制备方法和应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20211008 |
|
| RJ01 | Rejection of invention patent application after publication |